US Healthcare / PE-Owned
New CEO, –$200M FCF
→ Reset strategy and execution system with new CEO. 39% EBITDA CAGR. $300M+ free cash flow improvement.
Global Packaging / Family Office
No international growth strategy
Developed strategy and system. Executed expansion to #1 global leader in niche. 10X sales growth — $30M to $300M
Technology / NASDAQ
Stalled at $300M, needed inflection point
→ Simplified growth strategy. Expanded wholesale and retail markets. Beat 3-year profitability target by 20%. Company now over $1B.
B2B Industrials / Family Business
Moved from fossil fuel over-reliance to renewables. Reset leadership. +8% CAGR growth. EBITDA +11%.
Find out how
Global Pharma / NYSE
Global Pharma / NYSE: Customized strategies across all Latin America business units. CAGR +14% over 5+ years. EBITDA >14%
Learn more
Auto / PE-Family Office
Created long-term value creation platform and geographic expansion. Revenue 2X to $600M. EBITDA +7%.
Discover now